Aphelion Capital is a healthcare venture capital firm founded in 2005, based in Mill Valley, California. The firm invests in capital-efficient medical technologies, digital health, and biotechnology companies that improve patient outcomes at the same or lower cost to the healthcare system.
38% of their portfolio is in Healthcare. Average disclosed round size is $31.6M (across 10 rounds with reported amounts).
Portfolio
12
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| LLaplace Interventional Inc. | Series C | $22M | Mar 2025 |
 Venova Medical | Series B | $30M | Sep 2024 |
| NNectero Medical | Unknown | $96M | Apr 2024 |
 Phagenesis | Series D | — | Mar 2024 |
| NNectero Medical | Series D | — | Jan 2024 |
 Zeto | Series A | $7.3M | Mar 2020 |
| BBardyDx | Series B | — | Apr 2019 |
 Providence Medical Technology | Unknown | $25M | Sep 2018 |
| MMercator MedSystems | Series B | $6.5M | May 2013 |
 Biolinq | Series C | $100M | — |
 Orpyx | Series A | $7.6M | — |
| CCyMedica Orthopedics | Series A | $11.5M | — |
| FFreespira | Unknown | $10M | — |
Top Co-Investors
ShangBay Capital2 shared
Norwest Venture Partners2 shared
Corewell Health Ventures2 shared
SV Investment Corporation1 shared
Seraph Group1 shared
Capital Midwest Fund1 shared
BMO Capital Partners1 shared
Revelation Partners1 shared
EQT Life Sciences1 shared
Northern Gritstone1 shared
Sectoral Asset Management1 shared
British Patient Capital1 shared
RiverVest Venture Partners1 shared
Alpha Wave Global1 shared
M Ventures1 shared
LifeSci Venture Partners1 shared
Pegasus Tech Ventures1 shared
Ascension Ventures1 shared
HealthQuest Capital1 shared
Aperture Venture Partners1 shared
Last updated: 8 September 2026